State of Wisconsin Investment Board
CHRS icon

State of Wisconsin Investment Board’s Coherus Oncology CHRS Stock Holding History

State of Wisconsin Investment Board’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-126,886
Closed -$475K – 2408
2023
Q3 		$475K Sell
126,886
-62,683
-33% -$290K ﹤0.01% 1808
2023
Q2 		$809K Buy
189,569
+30,679
+19% +$181K ﹤0.01% 1549
2023
Q1 		$1.09M Buy
158,890
+47,128
+42% +$366K ﹤0.01% 1451
2022
Q4 		$885K Buy
111,762
+49,304
+79% +$379K ﹤0.01% 1556
2022
Q3 		$600K Sell
62,458
-3,390
-5% -$34.3K ﹤0.01% 1878
2022
Q2 		$477K Sell
65,848
-13,352
-17% -$116K ﹤0.01% 2088
2022
Q1 		$1.02M Hold
79,200
– – ﹤0.01% 1639
2021
Q4 		$1.26M Hold
79,200
– – ﹤0.01% 1377
2021
Q3 		$1.27M Hold
79,200
– – ﹤0.01% 1379
2021
Q2 		$1.09M Hold
79,200
– – ﹤0.01% 1423
2021
Q1 		$1.16M Sell
79,200
-4,100
-5% -$69.6K ﹤0.01% 1330
2020
Q4 		$1.45M Sell
83,300
-10,400
-11% -$185K ﹤0.01% 1253
2020
Q3 		$1.72M Sell
93,700
-2,400
-2% -$44.6K ﹤0.01% 1186
2020
Q2 		$1.72M Sell
96,100
-6,600
-6% -$112K ﹤0.01% 1152
2020
Q1 		$1.67M Buy
102,700
+9,900
+11% +$183K 0.01% 1104
2019
Q4 		$1.67M Hold
92,800
– – ﹤0.01% 1160
2019
Q3 		$1.88M Buy
92,800
+21,700
+31% +$434K 0.01% 1030
2019
Q2 		$1.57M Buy
71,100
+1,600
+2% +$27.8K ﹤0.01% 1054
2019
Q1 		$948K Buy
69,500
+15,900
+30% +$212K ﹤0.01% 1169
2018
Q4 		$485K Buy
53,600
+5,900
+12% +$68.3K ﹤0.01% 1323
2018
Q3 		$787K Sell
47,700
-29,490
-38% -$523K ﹤0.01% 1282
2018
Q2 		$1.08M Sell
77,190
-289,813
-79% -$4.15M ﹤0.01% 1146
2018
Q1 		$4.05M Sell
367,003
-551,997
-60% -$6.04M 0.01% 888
2017
Q4 		$8.09M Buy
919,000
+381,000
+71% +$4.08M 0.02% 716
2017
Q3 		$7.18M Buy
538,000
+200,000
+59% +$2.65M 0.02% 735
2017
Q2 		$4.85M Buy
+338,000
New +$6.5M 0.02% 841

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board's CHRS Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Coherus Oncology (CHRS) in Q4 2023, closing a stake of 126,886 shares — an estimated $475K sold.

State of Wisconsin Investment Board first reported a position in CHRS in Q2 2017 and held it in 26 quarters. The position peaked at $8.09M in Q4 2017. 156 funds tracked by Wall St. Rank hold CHRS as of Q4 2023.

  • State of Wisconsin Investment Board reported no remaining Coherus Oncology position as of Q4 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 126,886 Coherus Oncology shares in Q4 2023, an estimated $475K.
  • State of Wisconsin Investment Board first reported a position in Coherus Oncology in Q2 2017 and held it in 26 quarters.
  • State of Wisconsin Investment Board's Coherus Oncology position peaked at $8.09M in Q4 2017.
  • 156 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.